10.1038/nrendo.2017.151 Summary Keywords tirzepatide, GLP-1/GIP dual receptor agonist, glycemic management, weight control, cardiovascular health management Citation Yang J, Gu Y, Chen H, Wang H, Hong L, Li B and Yang L (2024) Tirzepatides innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health
Jimenez-Solem E, Rasmussen MH, Christensen M, Knop FK (2010) Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes
~ AlphaMD Testosterone replacement therapy (TRT) through telemedicine has made treatment more convenient than ever
What is the difference between FDA-approved brand-name drugs and compounded GLP-1 medications
Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al
ShresthaDBBudhathokiPSubediPKhadkaMKarkiPSedhaiYRet al